Pet Calming Treats Market Forecasts to 2034 - Global Analysis By Treat Format, Pet Type, Functional Ingredient, Use Occasion, Pet Life Stage, Purchase Channel, and By Geography

According to Stratistics MRC, the Global Pet Calming Treats Market is accounted for $0.6 billion in 2026 and is expected to reach $1.0 billion by 2034 growing at a CAGR of 6.6% during the forecast period. The market covers ingestible treats formulated to help manage situational stress and anxious behaviour in pets, including soft chews and biscuits. It is used to offer owners a convenient adjunct for noise events, travel and routine disruption. Growth reflects increased recognition of pet anxiety and premium functional-treat adoption. Further uptake will be shaped by technology readiness, customer confidence, pricing and the breadth of service networks.

Market Dynamics:

Driver:

Rising recognition of situational anxiety and demand for convenient calming formats

Greater owner awareness of noise, travel and separation-related stress is driving demand for calming treats that are easy to administer. Soft chews and functional biscuits fit daily routines and event-based use, while veterinary and trainer recommendations lend credibility. Premiumization of functional treats, human-grade ingredients and recognizable actives such as L-theanine and melatonin support repeat purchase. Retail and online availability, plus subscription replenishment, is broadening access beyond specialist channels. Owners increasingly seek products that combine palatability with a defined calming benefit.

Restraint:

Variable efficacy and ingredient transparency concerns

Calming treats face scrutiny because response varies by animal, trigger and formulation, and evidence for many botanical blends remains limited. Owners struggle to compare products when actives, dosages and claims differ widely, while veterinarians may hesitate to recommend unsubstantiated options. Palatability, treat-size suitability and calorie contribution also affect repeat use. Inconsistent quality and labeling across low-cost suppliers can erode trust and slow category growth. Clear dosing guidance and species suitability are essential to sustain credibility.

Opportunity:

Veterinarian-guided formulations and event-specific bundles

Opportunity lies in pairing calming treats with behavior plans, veterinary consultations and trainer guidance, positioning them as convenient adjuncts rather than stand-alone solutions. Event-specific bundles for fireworks, travel and clinic visits improve relevance and repeat purchase. Digital education, reminder programs and subscription formats can build loyalty. Species- and size-specific recipes, transparent actives and palatability testing can differentiate premium products in a crowded shelf. Partnerships with clinics, daycares and insurers can extend reach and credibility.

Threat:

Safety concerns and unsupported behavioral claims

Overstated calming claims, inappropriate use in medicated or medically compromised pets, and inconsistent ingredient quality can damage owner and veterinary trust. Regulatory scrutiny of functional claims varies by market, complicating labeling and marketing. Lower-priced substitutes and unverified online sellers pressure margins. Product recalls or adverse-event reports can harm brands quickly. Companies need traceable sourcing, clear contraindications and responsible promotion to sustain veterinary endorsement and protect reputation. Consistent quality assurance remains essential.

Covid-19 Impact:

The COVID-19 pandemic disrupted veterinary appointments, specialist retail, travel and pet-care supply chains, while shifting more purchasing and advice-seeking online. Some owners postponed non-urgent services, but increased time at home and heightened attention to animal wellbeing supported demand for home-use products and digital support. Providers responded with e-commerce, teleconsultation and flexible scheduling. As restrictions eased, in-person services recovered, but demand for convenience and clear product information remained. The effect varied by market, depending on clinical need, discretionary spending and reliance on in-person experiences where available.

The Soft Chews segment is expected to be the largest during the forecast period

The Soft Chews segment is expected to account for a leading share of the pet calming treats market during the forecast period. Its position reflects the relevance of this group to the addressable companion-animal population and the breadth of use across the market's principal treat format applications. Established product availability, owner familiarity and professional recommendations support demand, while a wide range of care needs encourages repeat purchasing or service use. Market participants are expected to prioritize this segment through targeted product development, broader distribution and clearer use guidance.

The Small Companion Animals segment is expected to have the highest CAGR during the forecast period

The Small Companion Animals segment is expected to have the highest CAGR during the forecast period as providers expand targeted solutions and improve access through veterinary, specialist retail and digital channels. Demand is supported by growing awareness of the relevant need, improved product formulation or service delivery, and increased owner willingness to invest in tailored companion-animal care. As evidence, convenience and availability improve, this segment may attract new entrants and encourage established providers to broaden their portfolios.

Region with largest share:

North America is expected to account for a leading share of the pet calming treats market, supported by high companion-animal ownership, comparatively developed veterinary infrastructure, established pet specialty retail and relatively high per-pet expenditure. The United States represents a major demand center because owners have access to veterinary clinics, online pet-care platforms and a broad selection of specialized products and services. Canada contributes through a mature pet-care ecosystem and established companion-animal health providers. Market adoption is also supported by insurance availability, consumer awareness and product innovation, although adoption differs by income, geography and veterinary access.

Region with highest CAGR:

Asia Pacific is expected to exhibit strong growth in the pet calming treats market as pet ownership, urban household formation, veterinary service availability and organized pet retail expand across major markets. China, Japan, South Korea, India and Australia offer different adoption pathways, reflecting differences in purchasing power, veterinary infrastructure, product regulation and the role of digital commerce. Growing awareness of preventive care and rising demand for premium companion-animal products are likely to support market development. Expansion will depend on localized products, professional education and compliance with national animal-health and consumer-protection requirements.

Key players in the market

Some of the key players in the Global Pet Calming Treats Market include Zesty Paws, PetHonesty, NaturVet, Pet Naturals of Vermont, VetriScience Laboratories, Nestle Purina PetCare, ThunderWorks, Finn, Pawfy, PetLab Co., Buddy & Lola, Only Natural Pet, Fera Pets, Calm Paws, Bocce's Bakery, Pet Releaf.

Key Developments:

In September 2026, Native Pet expanded from dog-only products into cat supplements, including daily probiotic, immune, hairball and calming formulas.

In September 2026, BARK, Inc. announced a dog treat collaboration with Girl Scouts, extending its branded pet treat and engagement portfolio through a limited product partnership.

In January 2026, KENT Worldwide introduced a pet wellbeing brand offering dual-benefit treats and supplements for cats and dogs, including digestive and targeted functional support.

Treat Formats Covered:

• Soft Chews
• Crunchy Functional Treats
• Biscuits and Bites
• Jerky and Treat Sticks

Pet Types Covered:

• Dogs
• Cats
• Small Companion Animals

Functional Ingredients Covered:

• L-Theanine and Tryptophan
• Melatonin-Based Formulas
• Botanical Blends
• Milk Protein and Peptide Blends

Use Occasions Covered:

• Noise and Firework Anxiety
• Separation Stress
• Travel and Transport
• Veterinary Visits and Grooming

Pet Life Stages Covered:

• Puppies and Kittens
• Adult Pets
• Senior Pets

Purchase Channels Covered:

• Veterinary Recommendation
• Specialty Pet Retail
• Online Direct-to-Consumer
• Mass-Market Retail

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
    • Saudi Arabia
    • United Arab Emirates
    • Qatar
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Egypt
    • Morocco
    • Rest of Africa

What our report offers:

• Market share assessments for regional and country-level segments
• Strategic recommendations for new entrants
• Covers market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032, and 2034
• Market trends, including drivers, constraints, opportunities, threats, challenges, investment opportunities, and recommendations
• Strategic recommendations for key business segments based on market estimations
• Competitive landscape mapping and assessment of key industry trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends and assessment of the latest technological advancements

Free Customization Offerings:

All customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, forecasts, and CAGR of any prominent country as per the client's interest (subject to feasibility assessment)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances